• SMAIO renewed Donald J. Blaskiewicz’s mandate on its North American scientific board for 12 months under unchanged terms.
• Remuneration remains mainly via BSA2026-02 warrants, with up to 25,000 instruments allocated to Blaskiewicz.
• Warrants are issued at EUR 3.33 each, payable in cash or by offsetting receivables.
• Each BSA2026-02 allows subscription to one new share over five years at EUR 7.61 per share.
• Full exercise would issue 25,000 shares, about 0.41% of current capital, reducing a 1% holding to 0.996%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SMAIO SA published the original content used to generate this news brief on September 03, 2026, and is solely responsible for the information contained therein.